Bank Of New York Mellon Corp Sellas Life Sciences Group, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.8 - $5.41 $37,497 - $112,701	20,832 New	20,832 $49,000
Q2 2022 Aug 15, 2022	SELL	$2.14 - $4.15 $1,562 - $3,029	-730 Reduced 3.48%	20,247 $45,000
Q3 2021 Nov 12, 2021	BUY	$8.21 - $10.53 $5,295 - $6,791	645 Added 3.17%	20,977 $192,000
Q2 2021 Aug 11, 2021	BUY	$7.19 - $13.71 $33,994 - $64,820	4,728 Added 30.3%	20,332 $225,000
Q1 2021 May 13, 2021	SELL	$5.5 - $11.71 $2,777 - $5,913	-505 Reduced 3.13%	15,604 $133,000
Q1 2020 May 06, 2020	BUY	$1.7 - $4.08 $27,385 - $65,724	16,109 New	16,109 $27,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.